Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?

Arjun Agarwal sold 10,290 shares on May 18, 2026 for approximately $608,000, based on a weighted average price of $59.07 per share. The transaction is an insider sale, which is generally a routine governance/data point rather than a direct operational signal. No other material business or financial developments were reported.

Analysis

Arjun Agarwal sold 10,290 shares on May 18, 2026 for approximately $608,000, based on a weighted average price of $59.07 per share. The transaction is an insider sale, which is generally a routine governance/data point rather than a direct operational signal. No other material business or financial developments were reported.